C
Halozyme Therapeutics, Inc. HALO
NASDAQ
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Revenue 230.04M 216.03M 221.04M 162.14M 181.50M
Total Other Revenue -- -- -- -- --
Total Revenue 230.04M 216.03M 221.04M 162.14M 181.50M
Cost of Revenue 73.63M 72.14M 69.80M 53.15M 64.69M
Gross Profit 156.41M 143.89M 151.24M 108.99M 116.81M
SG&A Expenses 37.61M 35.27M 38.95M 37.36M 15.85M
Depreciation & Amortization 15.26M 17.84M 17.84M 17.84M 4.55M
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 126.50M 125.25M 126.58M 108.34M 85.09M
Operating Income 103.54M 90.78M 94.46M 53.80M 96.41M
Income Before Tax 101.18M 101.76M 93.16M 52.24M 70.79M
Income Tax Expenses 15.79M 19.92M 18.40M 12.62M 13.09M
Earnings from Continuing Operations 85.39M 81.84M 74.75M 39.62M 57.70M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 85.39M 81.84M 74.75M 39.62M 57.70M
EBIT 103.54M 90.78M 94.46M 53.80M 96.41M
EBITDA 122.93M 109.96M 113.69M 72.86M 102.22M
EPS Basic 0.66 0.62 0.57 0.29 0.43
Normalized Basic EPS 0.49 0.43 0.44 0.24 0.42
EPS Diluted 0.65 0.61 0.56 0.29 0.42
Normalized Diluted EPS 0.48 0.42 0.44 0.23 0.41
Average Basic Shares Outstanding 129.05M 131.97M 131.73M 135.03M 135.28M
Average Diluted Shares Outstanding 131.04M 134.08M 133.54M 137.90M 138.60M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings